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Summary F344 rats were given saline, vitamin A placebo or vitamin A analogues orally for 4 consecutive
days. The following day they were killed and their alveolar macrophages (AMp) were harvested by lavage.
The functional integrity of the AM? was determined by their capacity to phagocytize opsonized SRBC and to
kill syngeneic adenocarcinoma cell lines nonspecifically. Results showed that 4 days treatment with > 100 IU
of vitamin A as retinyl palmitate per gram body weight rendered the AM? tumoricidal against syngeneic
mammary adenocarcinoma cell lines (MADB-100 and MADB-200) and that AMp activated with retinyl
palmitate showed increased ability to phagocytize opsonized SRBC. Other retinoids, such as retinoic acid and
retinol, had the same effect of inducing tumoricidal activity in rat AMT. AMT harvested from normal rats
were also rendered tumoricidal by direct interaction with > I03 IUml- 1 of retinyl palmitate for 24 h in vitro.
Thus, vitamin A at high doses can increase the phagocytic and tumoricidal activities of rat AMT.
The important role of cells of the macrophage-
histiocyte series in host defence against infection
and cancer is now recognized. Murine alveolar
macrophages (AMq,) obtained by lavage from
normal healthy donors are usually not cytotoxic to
tumour cells in vitro (Sone et al., 1980). These
noncytotoxic AMq, however, can be rendered
tumoricidal by interaction in vitro with bacterial
products, or lymphokines (Sone & Fidler, 1980,
1981). AM? can also be activated to kill tumour
cells by in vivo treatment with preparations of
bacteria such as Bacillus Calmette-Guerin, Coryne-
bacterium parvum, or cell wall skeletons of Nocardia
rubra (Olivotto & Bomford, 1974; Sone & Fidler,
1982; Zwilling & Campolito, 1977). The resultant
cytotoxic AM? should function as primary effector
cells against tumours growing in the lung. In fact,
there is encouraging evidence of a close association
of the tumoricidal activities of AM? and
eradication of pulmonary metastasis in mice (Fidler
et al., 1981; Sone & Fidler, 1982).
Vitamin A and its analogues are known to have
antitumour activity against chemical carcinogen-
induced or transplanted tumours (Bollag, 1971;
Kurata & Micksche, 1977; Moon et al., 1976;
Nettesheim & Williams, 1976; Saffioti et al., 1967;
Seifter et al., 1983). There is some evidence that
certain retinoids stimulate immune responses:
Vitamin A stimulates the induction of cell-mediated
cytotoxicity against tumours (Dennert & Lotan,
1978; Dennert et al., 1979; Lotan & Dennert, 1979),
enhances natural killer cell activity (Goldfarb &
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Herberman, 1981), accelerates graft rejection
(Floersheim & Bollag, 1972), augments lymphocyte
blastogenesis (Abb & Deinhardt, 1980; Lapin et al.,
1974; Micksche et al., 1977), and potentiates the
antitumour effect of BCG vaccine (Kurata &
Micksche, 1977). Retinoids also seem to stimulate
the function of the mononuclear phagocyte system,
since they have been found to augment defence
activity against infection with Listeria mono-
cytogenes (Hof & Emmerling, 1980). These findings
suggest that the antitumour effect of vitamin A and
its analogues might be mediated indirectly via
enhancement of host defence activities. Little is
known about activation and/or potentiation of
tumoricidal macrophages by vitamin A or its
analogues. AM(p may be important in host defence
against neoplastic cells developing and/or growing
in the lung. Since the lung is often used to evaluate
the inhibitory effect of vitamin A on chemical
carcinogenesis (Nettesheim & Williams, 1976;
Saffioti et al., 1967), it seemed of interest to
determine whether vitamin A could activate AM?
to destroy syngeneic tumour cells.
In this paper, we report that AM<p from F344
rats can be rendered cytotoxic to syngeneic tumour
cells by incubation in vitro with retinyl palmitate,
and also by oral administration of vitamin A to
1344 rats for 4 days.
Materials and methods
Animals
Specific pathogen-free inbred F344 male rats of 5-7
weeks old were obtained from the Shizuoka Animal
Facility Center (Shizuoka, Japan).
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Cell lines
The syngeneic tumours MADB-100 and MADB-
200 are mammary adenocarcinomas induced in
F344 rats given a single oral dose (20mg) of 9, 10-
dimethyl-1.2-benzanthracene (Sigma Chemical Co.,
St. Louis, Mo). Assays were always done with cells
from cultures in the exponential phase of growth.
Treatment ofanimals
Retinyl palmitate (Wako Pure Chemicals Co.,
Tokyo, Japan), retinol and retinoic acid (Sigma
Chemical Co., St. Louis, Mo) suspended in soybean
oil were given to rats at doses of 100-500 IU g
body wt through a plastic stomach tube.
Preparation andpurification ofAMcp
AMcp were obtained by the tracheobronchial lavage
method described fully elsewhere (Sone et al., 1980;
Sone & Fidler, 1981). Briefly, the lungs were
washed with 5ml of sterilized saline at 37°C. This
process was repeated several times to obtain a total
of 50ml of lavage fluid per rat. The total number
of cells collected was determined by cell counts in a
hemocytometer (using 2% acetic acid as diluent).
The viability of nucleated cells suspended in PBS,
measured by trypan blue dye exclusion, was >95%.
More than 95% of the lavage cells from normal
rats were AMq, judging by their positive staining
for non-specific esterase. The remaining cells were
small mononuclear cells or neutrophils, which were
eliminated during washing of plated cells (see
below). The lavage suspension was washed and
resuspended in RPMI 1640 medium supplemented
with 5% heat-inactivated foetal bovine serum
(FBS), penicillin G, and streptomycin (named
CRPMI 1640 medium), and 105 AM? were plated
into wells of a Microtest II plate (Falcon Plastics,
Oxnard, Calif.). Nonadherent cells (< 10%) were
removed by washing the plate 60min after plating.
At that time, >99% of the adherent cells were
mononuclear and could phagocytize carbon
particles.
In vitro activation ofAMc
Inocula of 105 AMqp were plated and the resulting
monolayers were washed 60min later. Then they
were incubated for 24h with or without retinyl
palmitate, muramyl dipeptide (MDP) (Calbiochem,
La Jolla, CA) or lipopolysaccharide (LPS) (E. coli
055:B5 Difco Laboratories, Detroit, MI). The
AM?p monolayers were then washed and assayed
for AMqp-mediated cytotoxicity.
Assay ofAMcp-mediated cytotoxicity in vitro
AMp-mediated cytotoxicity was assayed by
measuring release of radioactivity as described in
detail previously (Sone et al., 1980; Sone & Fidler,
1981). Target cells in the exponential growth phase
were incubated for 24h in medium containing
0.4 4uCi of [1251]iododeoxyuridine [1251]IUdRml - I
(Sp. act., 5Cimg- 1; Amersham International Ltd.,
Bucks, England). The target cells were then washed
to remove unbound radiolabel, harvested by brief
trypsinization, and resuspended in medium. Then
104-2 x 104 target cells per 105 AM9 were plated
in each well. No significant differences were detected
in the plating efficiencies of labelled target cells to
plastic and to monolayers of AM? (normal
activated). Radiolabelled target cells were re-fed
with fresh medium 14h after the plating of tumour
cells. The AMp-target cell cultures were then
incubated for another 58h at 37°C. Finally the
cultures we washed twice with PBS and adherent
(viable) cells were lyzed by adding 0.1ml of 0.5N
NaOH. The radioactivity of the lysate was
measured in a gamma counter. The cytotoxic
activity of the macrophages was calculated as
follows:
% cytotoxicity=
cpmin targetcells cpmintargetcells
culturedwithnormalAM? culturedwithtestAM?
cpm in target cells cultured with normal AM?
x 100
Quantitative assay ofphagocytosis
Opsonized sheep red blood cells (SRBC) labelled
with 5"Cr (0.2ml of 0.4% suspension) were added to
AM? monolayers in wells of 16mm diameter in
tissue culture dishes (Costar, Cambridge, Mass.)
(Moriguchi et al., 1983; Sone & Fidler, 1981). After
incubation for 2h at 37°C, the cultures were rinsed
once for 10sec with distilled water to lyse non-
phagocytized SRBC and washed twice with PBS.
The remaining adherent cells were lysed with 0.5N
NaOH, and the lysate was monitored for radio-
activity in a gamma counter. Values were obtained
from data in triplicate cultures.
Statistical analysis
The statistical significance of differences between
test groups was analyzed by Student's two-tailed t-
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Results
In vitro activation ofrat AM(p by vitamin A
Rat AM? obtained from the lungs of normal F344
rats were plated for 1 h in CRPMI 1640, and then
thoroughly washed and incubated for 24h in
medium with or without 5pgml-' LPS, 25kugml -1
MDP, or various amounts of vitamin A. Then the
AM? monolayers were washed and incubated with
2 x104 MADB-100 cells for 72h. AMp treated in
vitro with 103-5 x103IU retinyl palmitate showed
much less tumoricidal activity (14-21%) than that
ofcells treated with LPS (72%) or with MDP (42%)
(Table I).
Table I In vitro activation of tumoricidal activities of rat
AM? by retinyl palmitate
AMcp-mediated cytotoxicity
AM(p treatment against MADB-JOO
Tumour cells alone 2359+95k
Untreated AMp 2269+ 130
LPS 5jigmnl ' 627+42 (72%)b
MDP 25Mgml-1 1306+37 (42%)b
Retinyl palmitate
IUml-1 2283+239
10 ,, 2236+ 196
100 ,, 2142+ 162
1000 ,, 1955+76 (14%)b
10000 ,, 1786+ 137 (21%)b
50000 ,, 1863+66 (18%)b
100000 ,, 1905+152 (16%)b
aCpm+s.d. for triplicate cultures. Results were obtained
in 3 independent experiments.
bPercent cytotoxicity calculated from results with
tumour cells and untreated AMp (P<0.05).
Phagocytic ability ofvitamin A-treated rat AMp
Male F344 rats of 5-7 weeks old were given saline,
vitamin A placebo (soybean oil) or vitamin A
(250IUg-1 body wt) orally for 4 consecutive days,
and 24h later, their AMqp were harvested by lavage
of the lungs. There was no difference in the
numbers of AM(p obtained from the lungs of rats
given saline, vitamin A placebo and vitamin A. The
lavaged cells were plated for 60min in CRPMI
1640 and then thoroughly washed to obtain a
monolayer consisting of >99% AMp. The AM?
monolayers in Costar 24 wells of 16mm diameter
were tested for ability to phagocytize opsonized
SRBC labelled with 51Cr. The combined data from
3 independent experiments are summarized in
Figure 1. AM? from rats that received >250IU
retinyl palmitate g-1 body wt showed significantly
greater ability to phagocytize opsonized SRBC than
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Figure 1 Phagocytic activities of AMqp of rats given
vitamin A. Data are representative and were obtained
in one of 3 independent experiments. Values are means
+s.d.
those from rats given saline or vitamin A placebo
alone.
In vivo activation ofAMp by vitamin A
Next we examined whether oral administration of
vitamin A could render AM? tumoricidal. Rats
were given saline, vitamin A placebo or 250IU
vitamin A orally for one or 4 days and 24h after
the last administration, their AMqp were lavaged
and assayed for AMp-mediated cytotoxic activity.
As shown in Figure 2, administration of retinyl
palmitate for 4 days resulted in significant and
reproducible increase in AMq-mediated cytotoxicity
against MADB-100.
Dose response ofAMcp to vitamin A in vivo
F344 rats were given saline, vitamin A placebo or
different amounts of vitamin A orally for 4 days.
Twenty-four hours later, their AM? were lavaged
and plated. The indicated numbers of MADB-100
cells were added to the AM(p monolayers and
incubations were terminated 72h later. AMp from
rats given vitamin A at 100-500IUg- body wt
acquired the ability to lyse syngeneic tumour cells
in vitro. Under the same conditions, vitamin A
placebo, a preparation consisting of soybean oil
without vitamin A, did not render AM(p
significantly cytotoxic (Table II). In a parallel set of
experiments, AMq, activated in vivo with vitamin A
were incubated in CRPMI 1640, and at the
indicated times, 1.5 x 104 labelled MADB-100 cells
were added to the AMq monolayers. The
tumoricidal activity of vitamin A-treated AM? was
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Table II Induction of tumoricidal activities of AM? by oral administration of retinyl
palmitate
AMcp-mediated cytotoxicity
against MADB-JOO cells
Ratio of AMp/tumour target cells?
Treatment ofrats
5:1 10:1 20:1
No AMp, 3678+226b 2039+158 936+111
Saline 3457+ 197 2074+64 933+ 13
Vitamin A placebo 3501 + 180 1970+122 924+14
Retinyl 100IU 2511+135 (27%)c 1455+78 (30%)c 816+74
palmitate 250IU 2414+ 137 (30%)c 1460+86 (30%)c 805+80
500IU 2277+180 (34%)c 1375+51 (34%)c 718+59 (23%)c
aDifferent numbers of labelled MADB-100 cells to give the indicated ratio of
effector/target cells were added to the i05AM(p monolayers.
bCpm+s.d. for triplicate cultures.
cPercent cytotoxicity calculated from results with tumour cells and AMp from rats
given saline (P<0.05).
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Figure 2 Effect of duration of retinyl palmitate
administration on induction of AM(p-mediated
cytotoxicity. Rats were given vitamin A placebo or
retinyl palmitate (250 IUg-' body wt) orally once or
once a day for 4 days. AMp were plated for 60min
and then incubated with 104 labelled MADB-100 cells.
Percent cytotoxicity was calculated by comparison
with the value for AM<p from rats given saline. Points
are means + s.d. for triplicate cultures.
retained for 24-48h, but was gradually lost by 96h
after the start ofculture (Figure 3).
In vivo effects ofvitamin A analogues
Retinyl palmitate, retinol or retinoic acid in
soybean oil was given to F344 rats orally for 4 days
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Figure 3 In vitro maintenance of the tumoricidal state
of rat AMq after oral administration of vitamin A.
Percent cytotoxicity was calculated by comparison
with the value for AM<p from rats given saline. Points
are means + s.d. for triplicate cultures.
at a dose of 250IU g 1 body wt, and 24 h after the
last dose, the AM? were lavaged and assayed for
cytotoxic activity. Figure 4 shows that AMp from
rats given retinyl palmitate, retinol or retinoic acid
showed cytotoxic activity against syngeneic
mammary adenocarcinoma cell lines (MADB-100
and MADB-200).
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Figure 4 Effects of vitamin A analogues in in vivo
activation of AMcp. Retinyl palmitate (250IUg-1 body
wt) or retinol or retinoic acid (75pgg-1 body wt) was
given to rats orally for 4 days. AM9p were plated for
60min and then incubated with 104 labelled MADB-
100 or MADB-200 cells. Percent cytotoxicity was
calculated by comparison with values for the AM9
from rats treated with saline. Points are means + s.d.
for triplicate cultures.
Discussion
In the present studies, we demonstrated that (a) the
tumoricidal activities of rat AM?p could be induced
by treating the AMcp in vitro with retinyl palmitate;
(b) oral administration of retinyl palmitate to rats
resulted in increased ability of their AM? to
phagocytize opsonized SRBC and in generation of
tumoricidal activity of their AMcp; (c) on oral
administration, vitamin A analogues, such as
retinol and retinoic acid, also induced tumoricidal
activity of AM? to various extents.
Since retinyl palmitate was added to AMp mono-
layers consisting of >99% AM9 (with practically
no contaminating lymphocytes) the results in Table
I show that noncytotoxic AM9 from rats can
respond to a direct stimulus from retinyl palmitate
in vitro to become tumoricidal. Vitamin A is known
to affect tumour cell growth directly (Chopra &
Wilkopf, 1976). It is unlikely, however, that in the
in vitro cytotoxicity assay used in this study,
vitamin A inhibited tumour cell growth, since the
AM9 monolayers were thoroughly washed to
remove remaining vitamin A before the tumour
target cells were added. This conclusion is also
supported by the encouraging report that addition
of a vitamin A analogue, such as retinol or retinoic
acid, to cultures of human monocytes or guinea pig
macrophages resulted in reduction in their Fc
receptor functions but in enhancement of their
enzyme production (Rhodes & Oliver, 1980). Some
vitamin A analogues, as well as agents such as LPS,
pertussis or Mycobacterium butyricum, have been
shown to labilize lyosomal membranes (Spitznagel
& Allison, 1970). These agents also had marked
adjuvant effects, and there was a parallel between
their lyosome-labilizing capacity and their adjuvant
activity. However, it is unknown whether the
induction of tumoricidal activity in rat AMp by
vitamin A is related to lysosomal labilization, and
other possible mechanisms for activation of AMp
by vitamin A, cannot be excluded. For instance,
since vitamin A is known to stimulate lymphocyte
blastogenesis in vitro (Abb & Deinhard, 1980;
Lapin et al., 1974; Micksche et al., 1977), it is
conceivable that when vitamin A was given orally
the tumoricidal activity of AM? could be
potentiated via vitamin A-stimulated lymphocytes.
In any event, an increase by retinoids in the
functions of both the monocyte-macrophage series
and lymphocyte systems could account for the
antitumour effects observed in vivo in transplanted
tumour and carcinogenesis systems (Bollag, 1971;
Kurata & Micksche, 1977; Moon et al., 1976;
Nettesheim & Williams, 1976; Saffioti et al., 1967).
We found that of three vitamin A analogues
tested, all three retinoids (retinyl palmitate, retinol
and retinoic acid) induced tumoricidal activity of
rat AMp in vivo. The tumoricidal activity of AM?
was significant when rats were given vitamin A
orally for 4 days but not one day, suggesting that
administration of vitamin A for 4 days was
necessary for full activation of the tumoricidal
activities ofAM9 in vivo.
Large doses of vitamin A were necessary for in
vivo activation of the tumoricidal activity of AM(p
in the present work. However, the side effects of
vitamin A seem to be less when it is given orally
than when it is given i.p. or i.v. (Lapin et al., 1974;
Seifter et al., 1983). Since the lung is a frequent
target organ for carcinogenesis and cancer
metastasis in animals and humans, and there is
increasing evidence in animals that activated AM(p
are important in host defence against neoplasms in
the lung (Fidler et al., 1981; Sone & Fidler, 1982),
the present work suggests that use of vitamin A to
activate AM? in situ, in conjunction with other
procedures, such as immunotherapy, chemotherapy
and radiation therapy, might be of benefit in
treatment of primary and/or metastatic cancer in
the lung.
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